About 2EyesVision
2EyesVision is a company based in Madrid (Spain) founded in 2015 by Susana Marcos and Carlos Dorronsoro Diaz. 2EyesVision has raised $100 thousand across 6 funding rounds from investors including EIT Health, European Union and Luminate. 2EyesVision offers products and services including SimVis Gekko. 2EyesVision operates in a competitive market with competitors including Sensimed, i-Optics, Implandata, Olympic Ophthalmics and Inoveon, among others.
- Headquarter Madrid, Spain
- Founders Susana Marcos, Carlos Dorronsoro Diaz
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100 K (USD)
in 6 rounds
-
Latest Funding Round
$100 K (USD), Series A
Mar 16, 2021
-
Investors
EIT Health
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 2EyesVision
2EyesVision offers a comprehensive portfolio of products and services, including SimVis Gekko.
Simulates presbyopia corrections for personalized patient vision assessments.
Funding Insights of 2EyesVision
2EyesVision has successfully raised a total of $100K across 6 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 2EyesVision
2EyesVision has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, European Union and Luminate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AR/VR and biophotonics accelerator program is operated in Rochester.
|
Locked | Locked | Locked | |
|
High-tech Spanish startups are funded by Bullnet Capital.
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked |
Investor details for 2EyesVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 2EyesVision
Investment portfolio details for 2EyesVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 2EyesVision
Detailed financials for 2EyesVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
2Eyesvision Comparisons
Peer comparison for 2EyesVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 2EyesVision
2EyesVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, i-Optics, Implandata, Olympic Ophthalmics and Inoveon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| Locked | Locked | Locked |
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
|
|
| Locked | Locked | Locked |
Intraocular pressure is monitored continuously via an implantable microsensor.
|
|
| Locked | Locked | Locked |
Provider and developer of tear production device for treatments of dry eye disease
|
|
| Locked | Locked | Locked |
Eye disease detection services including diabetic retinopathy are provided.
|
|
| Locked | Locked | Locked |
Device for assessing the eye health against damaging light
|
Detailed competitors of 2EyesVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 2Eyesvision
Complete news archive for 2EyesVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 2EyesVision
2EyesVision was founded in 2015 and raised its 1st funding round 2 years after it was founded.
2EyesVision is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Carlos Dorronsoro Diaz is the current CEO of 2EyesVision. They have also founded this company.
2EyesVision is a funded company, having raised a total of $100K across 6 funding rounds to date.
Founded in 2015 in Madrid, Spain, the company operates in the medical technology sector, specializing in ophthalmology. Portable devices such as SimVis, an intraocular lens simulator, are provided for diagnostic purposes in cataract and refractive surgeries or contact lens fittings. Multifocal corrections are prescribed and binocular presbyopic options are compared using programmable features, a wide field-of-view, lightweight head-mounted design, and remote operation capabilities.
2EyesVision offers SimVis Gekko.
2EyesVision has 4 investors. Key investors include EIT Health, European Union, Luminate, and Bullnet Capital.